Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Chi Chou

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Therapeutic Advances in Medical Oncology|December 17, 2024
Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitorsLiang-Yun Cheng, Po-Jung Su, Ming-Chun Kuo, et al.
BMC Cancer|September 15, 2023
The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapyTsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, et al.
Human Pathology|October 23, 2025
Genitourinary mesenchymal neoplasms with tumor-defining genetic alterations: A clinicopathologic and molecular correlative study of 71 casesChih-Chi Chou, Jen-Chieh Lee, Pao-Shu Wu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Therapeutic Advances in Medical Oncology|December 17, 2024
Combining serum inflammatory markers and clinical factors to predict survival in metastatic urothelial carcinoma patients treated with immune checkpoint inhibitorsLiang-Yun Cheng, Po-Jung Su, Ming-Chun Kuo, et al.
BMC Cancer|September 15, 2023
The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapyTsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, et al.
Human Pathology|October 23, 2025
Genitourinary mesenchymal neoplasms with tumor-defining genetic alterations: A clinicopathologic and molecular correlative study of 71 casesChih-Chi Chou, Jen-Chieh Lee, Pao-Shu Wu, et al.
Pageof 2